BBP-472

N/A

Report date: 2024/05/14 15:17:23
NME

Base Information

Drug NameBBP-472
Drug Alias NameBBP-472
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase beta inhibitors
TargetsPhosphatidylinositol 3 kinase beta
Therapy Area/IndicationsAutistic Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBridgebio Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesBridgebio Pharma Inc
Inactive CompaniesN/A
Active IndicationsAutistic Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A